CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce ...

The Center for Biologics Evaluation and Research (CBER) of the FDA is also developing a regulatory approach to vaccine adjuvants and adjuvanted preventive vaccines for infectious disease indications.

Lipopolysaccharide functions as a vaccine adjuvant but is considered too toxic for clinical use. The major structural element responsible for its toxicity and adjuvant effect is lipid A.

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

A new nasal vaccine may help reduce the spread of whooping cough, a highly contagious respiratory disease that has been ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside ... followed by Keytruda and V940 given as adjuvant therapy. Specifically, it will ...

GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Company granted a non- qualified stock option and ...

Doctors encourage expecting mothers to get whooping cough, also known as pertussis, vaccine to help protect babies after ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer.

Nov. 18, 2024 — A new nasal whooping cough vaccine showed an ability to prevent both infection and transmission of the disease in mice. Current vaccines offer treatment but fail to halt ...